España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Sinopharm Gr Co
SHTDY
OTCPK
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$14.00
0.26
1.86%
Pre-Market: 9:12 AM EDT
Get Report
Comment
Sinopharm Gr Co (SHTDY) Forecast
News
Earnings
Sinopharm Gr Co (SHTDY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Sinopharm Gr Co (OTC:SHTDY) Stock
Sinopharm Gr Co Stock (OTC: SHTDY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 22, 2022
Jim Cramer Says China's Vaccines 'Don't Work' But Xi Won't Admit It
Adam Eckert
Wednesday, April 14, 2021
UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots
Vandana Singh
Monday, April 12, 2021
South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Reports
Vandana Singh
Thursday, April 08, 2021
Government, Officials Defend AstraZeneca's COVID-19 Shot: CNBC
Vandana Singh
Wednesday, April 07, 2021
Europe's Drug Watchdog Concludes Possible Link Between AstraZeneca COVID-19 Vaccine And Blood Clots
Vandana Singh
Wednesday, March 31, 2021
EMA May Issue Updated Recommendation If AstraZeneca Jab-Clot Link Is Established: Report
Vandana Singh
Pfizer-BioNTech's COVID-19 Vaccine Gives 100% Protection In Adolescents
Vandana Singh
Monday, March 29, 2021
White House Contemplates Waiving-Off Patent Protections For COVID-19 Treatments
Vandana Singh
Monday, March 22, 2021
AstraZeneca's COVID-19 Shot Shows 79% Efficacy In US Trials
Vandana Singh
Wednesday, March 17, 2021
Pfizer/BioNTech COVID-19 Vaccination Could Protect Pregnant Women, Newborns, Study In Israel Suggests: Reuters
Vandana Singh
Monday, March 15, 2021
Germany, France Join List Of Countries Suspending AZN's COVID-19 Vaccine; WHO Urges Not To Halt Vaccinations
Vandana Singh
Wednesday, March 10, 2021
Pfizer, BioNTech Predict Increase In Capacity To 3B COVID-19 Vaccine Shots In 2022: Bloomberg
Vandana Singh
Friday, March 05, 2021
WHO, SII Warn Of Raw Materials Shortage For COVID-19 Shots, Cites US Law As 'Serious' Limit:' Bloomberg
Vandana Singh
Thursday, March 04, 2021
Novartis Lends Support To Manufacture CureVac's COVID-19 Shots
Vandana Singh
Emergent BioSolutions Capable Of Manufacturing 1B COVID-19 Vaccine Doses Annually, CEO Says
Vandana Singh
Wednesday, March 03, 2021
EU Considers Emergency Approvals To Boost COVID-19 Vaccine Rollout: Reuters
Vandana Singh
Tuesday, March 02, 2021
European Officials Seek To Garner Support For AstraZeneca COVID-19 Shot: CNBC
Vandana Singh
Merck To Offer Hand With JNJ COVID-19 Vaccine Production, Biden Administration Says: Report
Vandana Singh
People Allergic To Pfizer, Moderna COVID-19 Vaccine Might Be Allowed To Get JNJ Shot: CNBC
Vandana Singh
AstraZeneca, Pfizer/BioNtech Single Shot COVID-19 Jab 80% Effective At Preventing Hospitalizations In Elderly
Vandana Singh
Novavax Bullish On Potential FDA EUA Nod For COVID-19 Vaccine By May
Vandana Singh
Friday, February 26, 2021
Johnson & Johnson's COVID-19 Vaccine Likely To Get EU Approval Early March: Bloomberg
Vandana Singh
Thursday, February 25, 2021
Moderna Raises 2021 Base COVID-19 Vaccine Production Plan To 700M Doses
Vandana Singh
Moderna To Test New COVID-19 Vaccine Targeting South Africa Strain
Vandana Singh
Tuesday, February 23, 2021
FDA Says Conduct Smaller Trials To Test Vaccine Efficacy Against COVID Variants
Vandana Singh
Monday, February 22, 2021
Sanofi/GlaxoSmithKline Initiate COVID-19 Vaccine Development After Setback
Vandana Singh
Thursday, February 18, 2021
Pfizer Says South African Variant Could Significantly Reduce Vaccine Protection: Reuters
Vandana Singh
Wednesday, February 17, 2021
Shortage Of Giant Sterile Liners Threatens Global Vaccines Rollout: FT
Vandana Singh
Thursday, February 11, 2021
Merck In Talks To Possibly Produce COVID-19 Shots: WSJ
Vandana Singh
Monday, February 08, 2021
South Africa Halts AstraZeneca's COVID-19 Vaccine Rollout On Efficacy Against Variant
Vandana Singh
Friday, February 05, 2021
Pfizer Drops India Vaccine Application After Regulator Seeks Local Trial - Reuters
Vandana Singh
Thursday, February 04, 2021
UK To Test Combining Pfizer And AstraZeneca Vaccines In Two-Shot Regimen - Reuters
Vandana Singh
Wednesday, February 03, 2021
European Medical Agency Starts Rolling Review Of Novavax's COVID-19 Vaccine Candidate
Vandana Singh
Switzerland Declines To Approve AstraZeneca COVID-19 Vaccine - Financial Times
Vandana Singh
GlaxoSmithKline, CureVac In Pact To Develop Vaccines For COVID-19 Variants
Vandana Singh
Tuesday, February 02, 2021
Moderna Proposes Filling Vials With Additional Doses Of COVID-19 Vaccine - Reuters
Vandana Singh
Friday, January 29, 2021
Johnson & Johnson To Start With 2 Million Doses COVID-19 Vaccine Supply
Mohit Manghnani
Thursday, January 28, 2021
Preliminary Study Finds Pfizer's COVID-19 Vaccine Effective Against UK, South Africa Variants: WSJ
Mohit Manghnani
Monday, January 25, 2021
Tata In Partnership Talks With Moderna To Launch COVID-19 Vaccine In India: Report
Mohit Manghnani
Friday, January 22, 2021
Johnson & Johnson Could Have 100 Million COVID-19 Vaccines By April, Board Member McClellan Says
Mohit Manghnani
Wednesday, December 30, 2020
A Peek Into The Markets: US Stock Futures Up; UK Approves AstraZeneca's Covid-19 Vaccine
Lisa Levin
AstraZeneca COVID-19 Vaccine Gets UK Nod For Emergency Use
Mohit Manghnani
China's Sinopharm COVID-19 Vaccine Shows 79.34% Efficacy
Mohit Manghnani
Wednesday, November 11, 2020
China's Sinopharm Says Data From Phase 3 Clin...
Benzinga Newsdesk
Friday, October 09, 2020
China Becomes Largest Economy To Join WHO-Backed Global COVID-19 Vaccine Initiative
Shivdeep Dhaliwal
Monday, October 05, 2020
Health Experts Concerned About China's Coronavirus Vaccine Rush
Mohit Manghnani
Thursday, September 24, 2020
Current Updates On COVID-19 Vaccines
IAM Newswire
Thursday, July 16, 2020
China's Sinopharm Begins Late Stage Trial of COVID-19 Vaccine in UAE
Charles Gross
Tuesday, March 24, 2020
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
Friday, February 28, 2020
Stocks That Hit 52-Week Lows On Friday
Lisa Levin
Show More